The Delhi High Court on Wednesday recorded a categorical undertaking from Sun Pharma that it will not market or sell its semaglutide product in India until the expiry of Novo ...
The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...
AT&T and its employee benefit trust have sued dozens of generic drug manufacturers in U.S. federal court, accusing them of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback